SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-012801
Filing Date
2024-03-12
Accepted
2024-03-12 16:05:52
Documents
15
Period of Report
2024-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20023953_8k.htm   iXBRL 8-K 27338
2 EXHIBIT 99.1 ef20023953_ex99-1.htm EX-99.1 166983
  Complete submission text file 0001140361-24-012801.txt   343483

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA siga-20240312.xsd EX-101.SCH 3853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20240312_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20240312_pre.xml EX-101.PRE 16036
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20023953_8k_htm.xml XML 4052
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

IRS No.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38436 | Film No.: 24742085
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)